TenNor Therapeutics sets 8 June 2026 board meeting to weigh potential final dividend

Bulletin Express05-27

TenNor Therapeutics (Suzhou) Limited has notified shareholders that its board of directors will convene on 8 June 2026. The primary agenda item is to deliberate on the recommendation of a final dividend, if any, for the most recent financial year.

As disclosed, the current board consists of one executive director—Chairman and CEO Dr. Ma Zhenkun—two non-executive directors, Dr. Song Gaoguang and Mr. Michael James Bakes, and three independent non-executive directors, Mr. Lee Wai Kong, Albert, Dr. Ni Lin and Dr. Li Leping.

The notice, released in Hong Kong on 27 May 2026, indicates that further details, including any dividend proposal, will follow the board’s deliberations. Investors and stakeholders are advised to monitor subsequent announcements for the board’s final resolution.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103043142?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-27 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103043142","market":"hk","top_or_hot":-1,"title":"TenNor Therapeutics sets 8 June 2026 board meeting to weigh potential final dividend","media":"Bulletin Express","content":"<p>TenNor Therapeutics (Suzhou) Limited has notified shareholders that its board of directors will convene on 8 June 2026. The primary agenda item is to deliberate on the recommendation of a final dividend, if any, for the most recent financial year.</p>\n<p>As disclosed, the current board consists of one executive director—Chairman and CEO Dr. Ma Zhenkun—two non-executive directors, Dr. Song Gaoguang and Mr. Michael James Bakes, and three independent non-executive directors, Mr. Lee Wai Kong, Albert, Dr. Ni Lin and Dr. Li Leping.</p>\n<p>The notice, released in Hong Kong on 27 May 2026, indicates that further details, including any dividend proposal, will follow the board’s deliberations. Investors and stakeholders are advised to monitor subsequent announcements for the board’s final resolution.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TenNor Therapeutics sets 8 June 2026 board meeting to weigh potential final dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenNor Therapeutics sets 8 June 2026 board meeting to weigh potential final dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-27 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TenNor Therapeutics (Suzhou) Limited has notified shareholders that its board of directors will convene on 8 June 2026. The primary agenda item is to deliberate on the recommendation of a final dividend, if any, for the most recent financial year.</p>\n<p>As disclosed, the current board consists of one executive director—Chairman and CEO Dr. Ma Zhenkun—two non-executive directors, Dr. Song Gaoguang and Mr. Michael James Bakes, and three independent non-executive directors, Mr. Lee Wai Kong, Albert, Dr. Ni Lin and Dr. Li Leping.</p>\n<p>The notice, released in Hong Kong on 27 May 2026, indicates that further details, including any dividend proposal, will follow the board’s deliberations. Investors and stakeholders are advised to monitor subsequent announcements for the board’s final resolution.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06872","symbol_name":"丹诺医药-B","start_time":0,"source_url":"","article_id":"1103043142","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103043142","pubTimestamp":1779877383,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TenNor Therapeutics (Suzhou) Limited has notified shareholders that its board of directors will convene on 8 June 2026. The primary agenda item is to deliberate on the recommendation of a final...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06872":"丹诺医药-B"},"translate_title":"TenNor Therapeutics定于2026年6月8日召开董事会会议，权衡潜在的末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06872":1},"content_text":"TenNor Therapeutics (Suzhou) Limited has notified shareholders that its board of directors will convene on 8 June 2026. The primary agenda item is to deliberate on the recommendation of a final dividend, if any, for the most recent financial year.\nAs disclosed, the current board consists of one executive director—Chairman and CEO Dr. Ma Zhenkun—two non-executive directors, Dr. Song Gaoguang and Mr. Michael James Bakes, and three independent non-executive directors, Mr. Lee Wai Kong, Albert, Dr. Ni Lin and Dr. Li Leping.\nThe notice, released in Hong Kong on 27 May 2026, indicates that further details, including any dividend proposal, will follow the board’s deliberations. Investors and stakeholders are advised to monitor subsequent announcements for the board’s final resolution.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103043142","isCrawlerRequest":true}